Genomic Identification of Multidrug-Resistant Salmonella Virchow Monophasic Variant Causing Human Septic Arthritis

Zhenyu Wang1,2,3, Haiyan Xu4, Chao Chu1,2,3

  • 1Key Laboratory of Prevention and Control of Biological Hazard Factors (Animal Origin) for Agri-Food Safety and Quality, Ministry of Agriculture of China, Yangzhou University, Wenhui East Road 48, Yangzhou 225009, China.

Insights

A novel multidrug-resistant Salmonella Virchow monophasic variant was identified in a child with septic arthritis. Whole-genome sequencing revealed genetic changes causing its unique characteristics and antimicrobial resistance, highlighting its importance for surveillance.

Area of Science:

  • Microbiology and Infectious Diseases
  • Genomics and Molecular Epidemiology
  • Antimicrobial Resistance Surveillance

Background:

  • The monophasic variant of *Salmonella* Typhimurium has globally increased, characterized by loss of second-phase flagella and multidrug resistance.
  • Emergence of novel *Salmonella* serovariants poses challenges to traditional identification methods and public health surveillance.

Purpose of the Study:

  • To characterize two *Salmonella* strains isolated from a pediatric septic arthritis case presenting with fever and knee effusion.
  • To identify the genomic basis for the non-expression of phase-2 flagellar antigens and multidrug resistance in the isolated strains.

Main Methods:

  • Classical slide agglutination test for initial serovar identification.
  • Whole-genome sequencing (WGS) for detailed genomic analysis.
  • Core-genome multi-locus sequence typing (cgMLST) and CRISPR typing for phylogenetic analysis and comparison with existing *S. Virchow* genomes.

Main Results:

  • The isolated strains were identified as a novel *Salmonella* Virchow monophasic variant (6,7,14:r:-) due to replacement of the *fljAB* operon by an *E. coli*-derived cassette.
  • cgMLST and CRISPR typing revealed a close genetic relationship to other *S. Virchow* strains and identified a unique CRISPR type (VCT12).
  • Acquisition of *Salmonella* genomic island 2 (SGI2) conferred multidrug resistance to chloramphenicol, tetracycline, trimethoprim, and sulfamethoxazole.

Conclusions:

  • The emergence of this multidrug-resistant *S. Virchow* monophasic variant underscores the need for advanced genomic surveillance.
  • WGS and CRISPR typing are effective tools for identifying *Salmonella enterica* serovariants and tracking their spread within surveillance systems.

Related Concept Videos